homeeconomy NewsGovt to bring policy to boost API manufacturing in India as coronavirus outbreak hit supply from China
Govt to bring policy to boost API manufacturing in India as coronavirus outbreak hit supply from China
The coronavirus outbreak has hit production of key pharma ingredients in China, and countries across the world including India are preparing themselves for the potential supply disruption and shortage of these ingredients.
The coronavirus outbreak has hit production of key pharma ingredients in China, and countries across the world including India are preparing themselves for the potential supply disruption and shortage of these ingredients.
Against the backdrop of supply disruption, India is preparing a blueprint to boost manufacturing of pharma raw materials.
Niti Aayog CEO Amitabh Kant, who is spearheading these efforts, chaired a meeting of all stakeholders on Wednesday. Secretaries from various government departments were part of the meeting, along with industry captains.
According to sources, ways to boost the active pharmaceutical ingredient (API) manufacturing in India were discussed in the meeting. The industry captains of pharma sector also said that India should look at a comprehensive policy to boost API manufacturing in the country on the similar lines.
Sources indicated that the government is already in talks with PMO to come up with a policy and it could come as early as this year itself.
First Published: Feb 19, 2020 9:57 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Punjab Lok Sabha elections: Complete list of Congress candidates
May 18, 2024 4:08 PM
Punjab Lok Sabha elections: Check full list of AAP candidates and constituencies
May 18, 2024 12:59 PM
PM Modi, Rahul Gandhi election rallies in Delhi today: Here are the routes to avoid
May 18, 2024 11:28 AM